There are three main effects of CTSK inhibitors: inhibition of PCa cell invasiveness, dose-dependent inhibition of PCa-conditioned mediator-induced bone resorption and the effective prevention of tumor formation. This evidence concerns the gene CTSK and posterior cortical atrophy.